Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node–Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score–Weighted Competing Risks Analysis-Reference-Cited by-同舟云学术

Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node–Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score–Weighted Competing Risks Analysis

Published:2018-03 Issue:2 Volume:4 Page:252-259
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Vetterlein Malte W.,Seisen Thomas,May Matthias,Nuhn Philipp,Gierth Michael,Mayr Roman,Fritsche Hans-Martin,Burger Maximilian,Novotny Vladimir,Froehner Michael,Wirth Manfred P.,Protzel Chris,Hakenberg Oliver W.,Roghmann Florian,Palisaar Rein-Jüri,Noldus Joachim,Pycha Armin,Bastian Patrick J.,Trinh Quoc-Dien,Xylinas Evanguelos,Shariat Shahrokh F.,Rink Michael,Chun Felix K.-H.,Dahlem Roland,Fisch Margit,Aziz Atiqullah

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v.1.0, cancer incidence and mortality worldwide. http://globocan.iarc.fr. Accessed April 9, 2016.

2. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma—neoadjuvant and adjuvant settings;Sternberg;Eur Urol,2013

3. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials;Leow;Eur Urol,2014

4. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial;Sternberg;Lancet Oncol,2015

5. Effectiveness of adjuvant chemotherapy for locally advanced bladder cancer;Galsky;J Clin Oncol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+);Cancers;2022-10-27

2. First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer;International Journal of Clinical Oncology;2022-08-27

3. Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder;Urologic Oncology: Seminars and Original Investigations;2022-06

4. Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer;The Prostate;2022-02-28

5. Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer;World Journal of Urology;2022-02-10